NeuroSearch A/S - Product Pipeline Review - 2012 - This pharmaceuticals report, "NeuroSearch A/S - Product Pipeline Review - 2012" provides data on the NeuroSearch A/S's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from our proprietary databases, NeuroSearch A/S's corporate website, SEC filings, investor presentations and featured press releases, both from NeuroSearch A/S and industry-specific third party sources, put together by This team.
Scope
- NeuroSearch A/S - Brief NeuroSearch A/S overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of NeuroSearch A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of NeuroSearch A/S with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the NeuroSearch A/S's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate NeuroSearch A/S's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of NeuroSearch A/S in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the NeuroSearch A/S's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with NeuroSearch A/S.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of NeuroSearch A/S and identify potential opportunities in those areas.
Keywords
Current R&D Portfolio of NeuroSearch A/S; NeuroSearch A/S - Key Therapeutics; NeuroSearch A/S - Pipeline Overview and Promising Molecules; NeuroSearch A/S - News; NeuroSearch A/S - Latest Updates; NeuroSearch A/S - Pipeline; NeuroSearch A/S - Discontinued/Dormant Projects
Table of Contents
Table of Contents
List of Tables
List of Figures
NeuroSearch A/S Snapshot
NeuroSearch A/S Overview
Key Information
Key Facts
NeuroSearch A/S - Research and Development Overview
Key Therapeutic Areas
NeuroSearch A/S - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
NeuroSearch A/S - Pipeline Products Glance
NeuroSearch A/S - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
NeuroSearch A/S Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
NeuroSearch A/S - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
NeuroSearch A/S - Drug Profiles
Huntexil
Product Description
Mechanism of Action
R&D Progress
NS2330
Product Description
Mechanism of Action
R&D Progress
NSD-708
Product Description
Mechanism of Action
R&D Progress
NSD-721
Product Description
Mechanism of Action
R&D Progress
NSD-726
Product Description
Mechanism of Action
R&D Progress
NSD-761
Product Description
Mechanism of Action
R&D Progress
NSD-788
Product Description
Mechanism of Action
R&D Progress
NSD-801
Product Description
Mechanism of Action
R&D Progress
NSD-847
Product Description
Mechanism of Action
R&D Progress
Ordopidine
Product Description
Mechanism of Action
R&D Progress
Seridopidine
Product Description
Mechanism of Action
R&D Progress
NeuroSearch A/S - Pipeline Analysis
NeuroSearch A/S - Pipeline Products by Therapeutic Class
NeuroSearch A/S - Pipeline Products by Route of Administration
NeuroSearch A/S - Pipeline Products By Mechanism of Action
NeuroSearch A/S - Recent Pipeline Updates
NeuroSearch A/S - Dormant Projects
NeuroSearch A/S - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
NS2330
ASP2314
NS2710
NeuroSearch A/S - Company Statement
NeuroSearch A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
NeuroSearch A/S, Recent Developments
NeuroSearch A/S- Press Release
Jun 22, 2012: NeuroSearch Announces Danish Medicines Agency's Conclusion On TIPO-1 Tesofensine Study Inspection
May 28, 2012: NeuroSearch Reports Conclusions From Multiple Ascending Dose Study With Huntexil
Oct 08, 2009: NeuroSearch Initiates A Clinical Study With ACR325 For The Treatment Of Dyskinesias In Parkinson's disease
Aug 25, 2009: NeuroSearch Achieves Approval For Huntexil As Brand Name For Pridopidine
Aug 04, 2009: NeuroSearch Successfully Advances NSD-721 For Treatment Of Social Anxiety Disorder And Receives EUR 5 million In Equity Financing Under The Alliance With GlaxoSmithKline
Financial Deals Landscape
NeuroSearch A/S, Deals Summary
NeuroSearch A/S, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
ZGene Secures $2.4 Million In Series D Financing
Partnerships
NeuroSearch Extends Research Agreement With Janssen Pharmaceutica
NeuroSearch Enters Into Co-Development Agreement With Janssen Pharmaceutica
NeuroSearch Enters Into Drug Discovery Agreement With Eli Lilly
NeuroSearch Expands Its Agreement With GlaxoSmithKline
GlaxoSmithKline Expands Collaboration With NeuroSearch
GlaxoSmithKline Enters Into An Agreement With NeuroSearch
Equity Offering
NeuroSearch Completes Rights Offering Of $86 Million
NeuroSearch Completes Private Placement Of $17.6 Million
NeuroSearch Completes Rights Offering For $149 Million
NeuroSearch Completes Rights Offering Of $69 million
Acquisition
Biolin Scientific Acquires Sophion Bioscience
NeuroSearch Acquires A. Carlsson Research
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
NeuroSearch A/S, Key Information
NeuroSearch A/S, Key Facts
NeuroSearch A/S - Pipeline by Indication, 2012
NeuroSearch A/S - Pipeline by Stage of Development, 2012
NeuroSearch A/S - Monotherapy Products in Pipeline, 2012
NeuroSearch A/S - Phase III, 2012
NeuroSearch A/S - Phase II, 2012
NeuroSearch A/S - Phase I, 2012
NeuroSearch A/S - Pre-Clinical, 2012
NeuroSearch A/S - Pipeline By Therapeutic Class, 2012
NeuroSearch A/S - Pipeline By Route of Administration, 2012
NeuroSearch A/S - Pipeline Products By Mechanism of Action, 2012
NeuroSearch A/S - Recent Pipeline Updates, 2012
NeuroSearch A/S - Dormant Developmental Projects,2012
NeuroSearch A/S - Discontinued Pipeline Products, 2012
NeuroSearch A/S, Subsidiaries
NeuroSearch A/S, Deals Summary
ZGene Secures $2.4 Million In Series D Financing
NeuroSearch Extends Research Agreement With Janssen Pharmaceutica
NeuroSearch Enters Into Co-Development Agreement With Janssen Pharmaceutica
NeuroSearch Enters Into Drug Discovery Agreement With Eli Lilly
NeuroSearch Expands Its Agreement With GlaxoSmithKline
GlaxoSmithKline Expands Collaboration With NeuroSearch
GlaxoSmithKline Enters Into An Agreement With NeuroSearch
NeuroSearch Completes Rights Offering Of $86 Million
NeuroSearch Completes Private Placement Of $17.6 Million
NeuroSearch Completes Rights Offering For $149 Million
NeuroSearch Completes Rights Offering Of $69 million
Biolin Scientific Acquires Sophion Bioscience
NeuroSearch Acquires A. Carlsson Research
List of Figures
NeuroSearch A/S - Pipeline by Indication, 2012
NeuroSearch A/S - Pipeline by Stage of Development, 2012
NeuroSearch A/S - Monotherapy Products in Pipeline, 2012
NeuroSearch A/S - Pipeline Products By Mechanism of Action, 2012 31